ATYR
aTyr Pharma
ATYR
ATYR
77 hedge funds and large institutions have $199M invested in aTyr Pharma in 2024 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.23% more ownership
Funds ownership: 63.15% → 65.38% (+2.2%)
18% less call options, than puts
Call options by funds: $195K | Put options by funds: $237K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
77
Holding in Top 10
–
Calls
$195K
Puts
$237K
Top Buyers
| 1 | +$17.7M | |
| 2 | +$3.26M | |
| 3 | +$2.64M | |
| 4 |
ABG
Ally Bridge Group
New York
|
+$2.53M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.37M |
Top Sellers
| 1 | -$4.72M | |
| 2 | -$3.62M | |
| 3 | -$3.45M | |
| 4 |
Renaissance Technologies
New York
|
-$2.08M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.63M |